Shrewsbury, MA, United States of America

Rajesh Thamatam

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Elysium Health, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajesh Thamatam. Retrieved from https://idiyas.com/inventor/rajesh-thamatam-i0dq1zuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajesh Thamatam: Innovator in Nicotinamide Riboside Synthesis

Introduction

Rajesh Thamatam is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of biochemistry, particularly in the synthesis of nicotinamide riboside. His innovative work has implications for therapeutic applications and health benefits.

Latest Patents

Rajesh Thamatam holds a patent for "Methods of synthesizing nicotinamide riboside." This patent outlines efficient and scalable methods for synthesizing nicotinamide riboside from riboside triacetate. Additionally, it includes compositions comprising nicotinamide riboside and therapeutic methods employing this compound.

Career Highlights

Rajesh is currently employed at Elysium Health, Inc., where he continues to advance research in health and wellness. His work focuses on developing innovative solutions that leverage the benefits of nicotinamide riboside.

Collaborations

Some of his notable coworkers include Eric Marcotulli and Dan Alminana. Their collaborative efforts contribute to the ongoing research and development at Elysium Health, Inc.

Conclusion

Rajesh Thamatam's contributions to the synthesis of nicotinamide riboside highlight his role as an innovator in the field of biochemistry. His work not only advances scientific knowledge but also has the potential to improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…